Evidence map›Paper›PMID 24791272›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2014

A microfluidic coculture and multiphoton FAD analysis assay provides insight into the influence of the bone microenvironment on prostate cancer cells.

Lauren L Bischel, Benjamin P Casavant, Pamela A Young, Kevin W Eliceiri, Hirak S Basu, David J Beebe

Abstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review of 3D Cell Culture with Analysis in Microfluidic Systems.Analytical methods : advancing methods and applications · 2019
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lauren L Bischel *Department of Biomedical Engineering, Wisconsin Institutes for Medical Research, University of Wisconsin, Madison, WI, USA.
Benjamin P Casavant *Department of Biomedical Engineering, Wisconsin Institutes for Medical Research, University of Wisconsin, Madison, WI, USA.
Pamela A YoungLaboratory for Optical and Computational Instrumentation, University of Wisconsin, Madison, WI, USA.
Kevin W EliceiriDepartment of Biomedical Engineering, Wisconsin Institutes for Medical Research, University of Wisconsin, Madison, WI, USA.
Hirak S BasuLaboratory for Optical and Computational Instrumentation, University of Wisconsin, Madison, WI, USA.
David J BeebeDepartment of Biomedical Engineering, Wisconsin Institutes for Medical Research, University of Wisconsin, Madison, WI, USA.
University of Wisconsin–Madison · USWisconsin Institutes for Discovery · US

Funding

RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer PrognosisR01CA185251 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BASU, HIRAK S., BEEBE, DAVID J · 2014 to 2017
$2.9M
Development of The Prairie Technologies MPLSM to image cancer models in vivoR01CA136590 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CAMPAGNOLA, PAUL J, KEELY, PATRICIA J · 2009 to 2013
$2.4M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
Microchannel cell-based assays to enable cancer researchR33CA137673 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J · 2009 to 2011
$1.4M
PULMONARY PATHOGEN DEFENSE MECHANISMST32HL007889 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, HENRY · 1998 to 2007
$1.1M
Validation of Biomarkers to Distinguish Aggressive from Indolent Prostate CancerR21CA176218 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BASU, HIRAK S. · 2013 to 2014
$370k
NCI NIH HHS R01 CA136590NCI NIH HHS R01 CA185251NCI NIH HHS R21 CA176218NCI NIH HHS R21CA176218-01NCI NIH HHS R33 CA137673NCI NIH HHS R33CA160244NHLBI NIH HHS T32 HL007889NHLBI NIH HHS T32HL007889NHLBI NIH HHS T32 HL007899NIBIB NIH HHS R01 EB010039NIBIB NIH HHS R01EB10039
6 · The paper itself

Abstract

In prostate cancer, bone is a frequent site of metastasis; however, the molecular mechanisms of this tumor tropism remain unclear. Here, we integrate a microfluidic coculture platform with multi-photon imaging based techniques to assess both phenotypic cell behavior and FAD fluorescence intensity and fluorescence lifetime in the same cell. This platform combines two independent assays normally performed with two different cell populations into a single device, allowing us to simultaneously assess both phenotypic cell behavior and enzyme activity. We observed that the osteotropic prostate cancer cell line (C4-2B), when in a coculture with bone marrow stromal cells (MC3T3-E1), has increased protrusive phenotype and increased total and protein-bound FAD compared to its parent cell line (LNCaP). We hypothesized that an increase in ROS-generating APAO activity may be responsible for these effects, and found that the effects were decreased in the presence of the antioxidant N-Acetyl Cysteine (NAC). This suggests that an ROS-related signaling mechanism at the bone metastatic site may be correlated with and play a role in increased invasion of metastasizing prostate cancer cells. The studies performed using this combined platform will lead to new insights into the mechanisms that drive prostate cancer metastasis.

Indexed as

AcetylcysteineCell Line, TumorCoculture TechniquesFlavin-Adenine DinucleotideHumansMaleMesenchymal Stem CellsMicrofluidicsMicroscopy, Fluorescence, MultiphotonProstatic NeoplasmsReactive Oxygen SpeciesAcetylcysteineFlavin-Adenine DinucleotideReactive Oxygen Species

Identifiers

PMID24791272
PMCPMC4077588
OpenAlexW2115624505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.